Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial.

Bizzarri C, Pitocco D, Napoli N, Di Stasio E, Maggi D, Manfrini S, Suraci C, Cavallo MG, Cappa M, Ghirlanda G, Pozzilli P; IMDIAB Group.

Diabetes Care. 2010 Sep;33(9):1962-3. doi: 10.2337/dc10-0814.

PMID:
20805274
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI).

Pitocco D, Crinò A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, Anguissola GB, Visalli N, Suraci C, Matteoli MC, Patera IP, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group.

Diabet Med. 2006 Aug;23(8):920-3.

PMID:
16911633
[PubMed - indexed for MEDLINE]
3.

A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX).

Crinò A, Schiaffini R, Manfrini S, Mesturino C, Visalli N, Beretta Anguissola G, Suraci C, Pitocco D, Spera S, Corbi S, Matteoli MC, Patera IP, Manca Bitti ML, Bizzarri C, Pozzilli P; IMDIAB group.

Eur J Endocrinol. 2004 May;150(5):719-24.

PMID:
15132730
[PubMed - indexed for MEDLINE]
Free Article
4.

Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials.

Schloot NC, Meierhoff G, Lengyel C, Vándorfi G, Takács J, Pánczél P, Barkai L, Madácsy L, Oroszlán T, Kovács P, Sütö G, Battelino T, Hosszufalusi N, Jermendy G.

Diabetes Metab Res Rev. 2007 May;23(4):276-85.

PMID:
17103487
[PubMed - indexed for MEDLINE]
5.

Effect of calcitriol on bone turnover and osteocalcin in recent-onset type 1 diabetes.

Napoli N, Strollo R, Pitocco D, Bizzarri C, Maddaloni E, Maggi D, Manfrini S, Schwartz A, Pozzilli P; IMDIAB Group.

PLoS One. 2013;8(2):e56488. doi: 10.1371/journal.pone.0056488. Epub 2013 Feb 20.

PMID:
23437144
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial.

Raz I, Avron A, Tamir M, Metzger M, Symer L, Eldor R, Cohen IR, Elias D.

Diabetes Metab Res Rev. 2007 May;23(4):292-8.

PMID:
17124720
[PubMed - indexed for MEDLINE]
7.

Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes.

Picardi A, Visalli N, Lauria A, Suraci C, Buzzetti R, Merola MK, Manfrini S, Guglielmi C, Gentilucci UV, Pitocco D, Crinò A, Bizzarri C, Cappa M, Pozzilli P.

Horm Metab Res. 2006 Oct;38(10):668-72.

PMID:
17075776
[PubMed - indexed for MEDLINE]
8.

No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes.

Walter M, Kaupper T, Adler K, Foersch J, Bonifacio E, Ziegler AG.

Diabetes Care. 2010 Jul;33(7):1443-8. doi: 10.2337/dc09-2297. Epub 2010 Mar 31.

PMID:
20357369
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.

Pozzilli P, Pitocco D, Visalli N, Cavallo MG, Buzzetti R, Crinò A, Spera S, Suraci C, Multari G, Cervoni M, Manca Bitti ML, Matteoli MC, Marietti G, Ferrazzoli F, Cassone Faldetta MR, Giordano C, Sbriglia M, Sarugeri E, Ghirlanda G.

Diabetologia. 2000 Aug;43(8):1000-4.

PMID:
10990077
[PubMed - indexed for MEDLINE]
10.

Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study)

Pozzilli P, Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E, Mesturino C, Fiori R, Romiti A, Giovannini C, Lucentini L, Matteoli MC, Crinò A, Teodonio C, Paci F, Amoretti R, Pisano L, Suraci C, Multari G, Suppa M, Sulli N, De Mattia G, Faldetta MR.

Eur J Endocrinol. 1997 Sep;137(3):234-9. Erratum in: Eur J Endocrinol 1997 Nov;137(5):558. Suraci MT [corrected to Suraci C].

PMID:
9330586
[PubMed - indexed for MEDLINE]
Free Article
11.

Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).

Pozzilli P, Visalli N, Signore A, Baroni MG, Buzzetti R, Cavallo MG, Boccuni ML, Fava D, Gragnoli C, Andreani D, et al.

Diabetologia. 1995 Jul;38(7):848-52.

PMID:
7556988
[PubMed - indexed for MEDLINE]
12.

The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control.

Petrone A, Spoletini M, Zampetti S, Capizzi M, Zavarella S, Osborn J, Pozzilli P, Buzzetti R; Immunotherapy Diabetes (IMDIAB) Group.

Diabetes Care. 2008 Jun;31(6):1214-8. doi: 10.2337/dc07-1158. Epub 2008 Feb 5.

PMID:
18252906
[PubMed - indexed for MEDLINE]
13.

Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control.

Chaillous L, Bouhanick B, Kerlan V, Mathieu E, Lecomte P, Ducluzeau PH, Delamaire M, Sonnet E, Maugendre D, Maréchaud R, Rohmer V, Saï P, Charbonnel B.

Diabetes Metab. 2010 Feb;36(1):64-70. doi: 10.1016/j.diabet.2009.07.004. Epub 2010 Jan 8.

PMID:
20060765
[PubMed - indexed for MEDLINE]
Free Article
14.

No effect of the altered peptide ligand NBI-6024 on beta-cell residual function and insulin needs in new-onset type 1 diabetes.

Walter M, Philotheou A, Bonnici F, Ziegler AG, Jimenez R; NBI-6024 Study Group.

Diabetes Care. 2009 Nov;32(11):2036-40. doi: 10.2337/dc09-0449. Epub 2009 Aug 18.

PMID:
19690081
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The effects of calcitriol and nicotinamide on residual pancreatic beta-cell funtion in patients with recent-onset Type 1 diabetes (IMDIAB XI).

Boucher BJ.

Diabet Med. 2007 Feb;24(2):219; author reply 219-20. No abstract available.

PMID:
17257289
[PubMed - indexed for MEDLINE]
16.

Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial.

Coutant R, Landais P, Rosilio M, Johnsen C, Lahlou N, Chatelain P, Carel JC, Ludvigsson J, Boitard C, Bougnères PF.

Diabetologia. 1998 Sep;41(9):1040-6.

PMID:
9754822
[PubMed - indexed for MEDLINE]
17.

Use of technology to potentially preserve C-Peptide in type 1 diabetes mellitus.

Danne T, Kordonouri O.

Pediatr Endocrinol Rev. 2010 Aug;7 Suppl 3:396-400. Review.

PMID:
20877252
[PubMed - indexed for MEDLINE]
18.

Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.

Chaillous L, Lefèvre H, Thivolet C, Boitard C, Lahlou N, Atlan-Gepner C, Bouhanick B, Mogenet A, Nicolino M, Carel JC, Lecomte P, Maréchaud R, Bougnères P, Charbonnel B, Saï P.

Lancet. 2000 Aug 12;356(9229):545-9.

PMID:
10950231
[PubMed - indexed for MEDLINE]
19.

Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus.

Bonfanti R, Bazzigaluppi E, Calori G, Riva MC, Viscardi M, Bognetti E, Meschi F, Bosi E, Chiumello G, Bonifacio E.

Diabet Med. 1998 Oct;15(10):844-50.

PMID:
9796885
[PubMed - indexed for MEDLINE]
20.

Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D, Hu Y, Zhou Z, Yan X, Tian H, Ran X, Luo Z, Xian J, Yan L, Li F, Zeng L, Chen Y, Yang L, Yan S, Liu J, Li M, Fu Z, Cheng H.

Lancet. 2008 May 24;371(9626):1753-60. doi: 10.1016/S0140-6736(08)60762-X.

PMID:
18502299
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk